Status:
UNKNOWN
Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease
Lead Sponsor:
Laval University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Quebec Heart Institute
Conditions:
Panic Disorder
Generalized Anxiety Disorder
Eligibility:
All Genders
18+ years
Brief Summary
The primary aim of this study is to establish how frequently patients with coronary artery disease present or develop two anxiety disorders (panic disorder and generalized anxiety disorder) in the two...
Detailed Description
Coronary artery disease (CAD), the most common form of cardiovascular disease, affects approximately 1 in 12 adults in Canada. CAD is a major public health concern and is one of the costliest chronic ...
Eligibility Criteria
Inclusion
- All adult patients (18 years of age or older) who undergo a revascularization procedure for CAD at the Quebec Heart and Lung Institute and who write/speak French will be eligible for study participation.
Exclusion
- Patients will be excluded if they present a severe communication problem or suffer from a terminal illness, a diagnosed major cognitive deficit, or any other condition that could invalidate the interview (e.g. psychotic disorder).
Key Trial Info
Start Date :
January 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
3610 Patients enrolled
Trial Details
Trial ID
NCT04433832
Start Date
January 20 2020
End Date
November 30 2023
Last Update
October 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quebec Heart and Lung Institute/Institut universitaire de cardiologie et de pneumologie de Québec
Québec, Canada, G1V4G5